Contrast Media Injectors Market 2022 | Present Scenario and Growth Prospects 2022-2030
FMI, an ESOMAR-certified market research firm, estimates global contrast media injectors market revenues to reach US$ 1.5 Bn in 2022. In its new study, FMI takes a long-term optimistic view of the market, estimating global revenues to grow at 6.2% CAGR through 2030. The report opines that AI’s growing penetration in the healthcare sector will also rub off on contrast media injectors industry during the next decade.
Key Takeaways of Contrast Media Injectors Market Study
- North
America is expected to be the most lucrative region and account for more
than 32% of revenue in the global contrast media injectors in 2022 and
this trend is expected to continue during the forecast period
- Larger
patient pool and increasing government support towards developing
healthcare system in Asian countries are expected to propel the growth of
the contrast media injectors market in the region
Click to get Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-823
- AI
is expected to speed up the process of injecting contrast media in the
forecast period
- Increasing
applications in orthopedic surgeries and neurosurgeries to bolster the
market in the forecast period
“Development of advanced contrast media injectors
including automated and IT/software technology at low cost is the major focus
area of the manufacturers, which provides a competitive advantage” says an FMI
Analyst.
New Product Launches and Approval – The Ongoing Trend
The market players are into getting their new products
launched as well as approved to stay in the competition and also keep pace with
the market scenario (that of continuing to innovate). The constructive steps in
this regard are:
- In
Apr 2022, Guerbet announced getting approved by the US FDA for
manufacturing gadoterate meglumine (Dotarem) injection inside the US. Till
late 2019, this production used to happen outside of the US.
- In
Nov 2021, the US FDA approved an MRI contrast agent “Clariscan” for
intravenous use in spine, brain (intracranial), and associated tissues.
- In
Aug 2021, Bracco Diagnostics, Inc. announced getting approved by the US
FDA for oral suspension of barium sulfate (Varibar Thin Liquid). The basic
use of this contrast agent is detection and assessment of dysphagia.
What else is in the report?
Future market insights offer actionable insights and unique
perspective on contrast media injectors market in its latest study, presenting
historical demand assessment from 2014 – 2021 and projections from 2022–2030
based on product type (angiographic injectors, magnetic resonance imaging (MRI)
injectors, computed tomography (CT) injectors), by end-user (hospital,
ambulatory surgical centres, diagnostics centres) in seven key regions
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government,
investors, and associated audiences in the healthcare sector to
identify and accentuate vital aspects applicable to product strategy,
regulatory landscape, technology evolution, and other crucial issues to achieve
sustainable success. Our unique approach to gathering market intelligence
equips you in devising innovation-driven trajectories for your business. Know
more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market
intelligence and consulting services, serving clients in over 150 countries.
FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and
India. FMI's latest market research reports and industry analysis
help businesses navigate challenges and make critical decisions with confidence
and clarity amidst breakneck competition. Our customized and syndicated
market research reports deliver actionable insights that drive sustainable
growth. A team of expert-led analysts at FMI continuously tracks emerging
trends and events in a broad range of industries to ensure that our clients
prepare for the evolving needs of their consumers.
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Comments
Post a Comment